Agilent Technologies Inc at Evercore ISI HealthCONx Virtual Conference Transcript

Dec 01, 2021 / 04:20PM GMT
Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - Senior MD

Okay. Morning, everyone. Thanks for joining us for the next session. Pleased to have Agilent with us. We have the CEO, Mike McMullen; CFO, Bob McMahon. And I think Parmeet and Mark, who head the Investor Relations efforts, so they're perhaps in the background. But Mike, Bob, thank you both for taking the time this morning. Thank you for being here.

Michael R. McMullen - Agilent Technologies, Inc. - CEO, President & Director

Yes. Thanks for the kind invitation. Bob and I are very excited about -- to spend time with you and your clients today.

Questions and Answers:

Vijay Muniyappa Kumar - Evercore ISI Institutional Equities, Research Division - Senior MD

Fantastic. I think -- if I just reflect back on fiscal '21, it's previously been remarkable for Agilent, how the rate went from Q-on-Q. I just -- the execution has been picture perfect. And when I think about your Q1 guidance, I think I'll round it out to 6% to 7%, but
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot